全球微创青光眼手术 (MIGS) 设备市场 – 2029 年行业趋势和预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Medical Devices Global Micro Invasive Glaucoma Surgery Migs Devices Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球微创青光眼手术 (MIGS) 设备市场 – 2029 年行业趋势和预测

  • Medical Devices
  • Published Report
  • Aug 2022
  • Global
  • 350 页面
  • 桌子數： 208
  • 图号： 39
立即购买 立即购买

>全球微创青光眼手术 (MIGS) 设备市场，按产品（MIGS 支架、MIGS 分流器等）、目标（小梁网脉络膜上腔结膜下滤过和减少房水产生）、手术类型（合并白内障的青光眼和独立的青光眼）、最终用户（医院门诊部 (HOPD)、眼科诊所、门诊手术中心(ASCS) 等）、分销渠道（直接招标和零售销售）- 行业趋势和预测到 2029 年。

微创青光眼手术 (MIGS) 设备市场

微创青光眼手术 (MIGS) 设备市场分析和规模

微创青光眼手术用于治疗开角型青光眼。最初，为了治疗开角型青光眼，医生会使用药物减少房水产生或增加房水流出。对于轻度至中度的开角型青光眼，传统上会进行药物和激光治疗。随着微创青光眼手术 (MIGS) 的出现，为不适合进行传统手术的患者创造了新的选择。老年人口的增加和政府预防失明的举措的增加预计将推动市场的发展。从青光眼药物到微创青光眼手术的快速转变可能会为 MIGS 设备制造商创造机会。然而，较差的报销设施可能会成为市场发展的障碍。

微创青光眼手术 (MIGS) 设备市场

微创青光眼手术 (MIGS) 设备市场

微创手术需求的上升是由于眼部疾病发病率的上升、微创手术需求的上升以及手术创伤的减少，从而推动了预测期内市场的需求。然而，高昂的安装成本和熟练专业人员的短缺可能会阻碍预测期内微创手术市场的增长。

Data Bridge Market Research 分析，微创青光眼手术 (MIGS) 设备市场预计到 2029 年将达到 59.9546 亿美元的价值，预测期内的复合年增长率为 33.3%。由于微创青光眼手术 (MIGS) 设备商业化的技术途径发展迅速，“MIGS 支架”占据了微创青光眼手术 (MIGS) 设备市场中最大的技术细分市场。微创青光眼手术 (MIGS) 设备市场报告还深入介绍了技术进步。

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020（可定制至 2019 - 2014）

定量单位

收入（百万美元）

涵盖的领域

按产品（MIGS 支架、MIGS 分流器等）、目标（小梁网脉络膜上腔结膜下滤过和减少房水产生）、手术类型（合并白内障的青光眼和独立青光眼）、最终用户（医院门诊部 (HOPD)、眼科诊所、门诊手术中心 (ASCS) 等）、分销渠道（直接招标和零售）

覆盖国家

北美洲的美国、加拿大、墨西哥。欧洲的英国、德国、法国、西班牙、意大利、荷兰、瑞士、俄罗斯、比利时、土耳其、欧洲其他地区。亚太地区的中国、韩国、日本、印度、澳大利亚、新加坡、马来西亚、印度尼西亚、泰国、菲律宾、亚太其他地区。中东和非洲的南非、沙特阿拉伯、阿联酋、以色列、埃及、中东和非洲其他地区 (MEA)。南美洲的巴西、阿根廷和南美洲其他地区。

涵盖的市场参与者

AbbVie、BVI、Ellex、Glaukos Corporation、强生、爱尔康、Microsurgical technology、New World Medical、参天制药、Nova Eye Medical Limited、Belkin Vision 和 Sight Scientific 等。

市场定义

MIGS 代表微创青光眼手术，有助于治疗青光眼。这是治疗轻度至中度青光眼的一项突破性技术。它是之前药物治疗的替代品，还可以预防传统手术的并发症。这些手术用于降低眼内压，避免损伤视神经。与传统手术相比，这些手术更安全，恢复时间非常快。植入的各种 MIGS 设备包括分流器和支架，用于降低眼压。

微创青光眼手术 (MIGS) 设备市场动态

  • 老年人口增加

老年人面临的一个重大健康问题是视力丧失。根据美国家庭医生学会的数据，到 65 岁时，三分之一的人患有视力下降的眼病。老年人口正在迅速增加。因此，老年人对治疗青光眼的先进技术的需求也随之增加。因此，老年人口的增加是市场发展的驱动力。

  • 全球青光眼发病率上升

不可逆性全盲的主要原因是青光眼。青光眼是一组眼部疾病，初期症状很少或没有症状，但随后会导致视神经受损，从而导致视力丧失或失明。青光眼的患病率一直在上升。因此，这产生了对 MIGS 设备的需求；因此，青光眼发病率的上升预计将成为市场发展的驱动力。

  • 政府采取措施提高公众对预防失明的认识

据世界卫生组织称，至少有 22 亿人患有视力障碍和失明，其中至少有 10 亿人的视力障碍是可以预防的。为了预防这些情况，全球多个国家的政府都采取了举措。这产生了对微创青光眼手术等先进治疗的需求，从而推动了 MIGS 设备市场的发展。因此，它有望成为市场的驱动力。

  • 技术先进产品介绍

青光眼是一种严重的眼部疾病，如果不加以控制，会导致视力丧失。它通常不会导致失明，因为它可以通过现代治疗和许多防止进一步损害的选择来控制。随着科学的发展，青光眼的治疗发生了革命性的变化。随着微创青光眼手术的出现，医学发生了范式转变，因为它可以帮助早期治疗青光眼，避免对小梁切除术等过滤手术的依赖。这也克服了与这些切口手术相关的风险。使用 MIGS 治疗青光眼有各种进展。

市场面临的限制/挑战

  • MIGS 设备的严格规定

在美国，任何设备制造商必须完全遵守至少 7 项法规，即企业注册和医疗器械清单、上市前通知 510(k)、上市前批准 (PMA)（仅适用于第三类设备）、临床研究的试验设备豁免 (IDE)、质量体系 (QS) 法规、标签要求和医疗器械报告 (MDR)。这些风险最高的设备需要更严格的上市前申请监管流程来证明安全性和有效性的有效证据。漫长的时间表会导致获取延迟，这可能会限制 MIGS 设备的市场。

微创青光眼手术 (MIGS) 设备市场

  • 手术费用高昂

虽然青光眼治疗效果一般，而且比传统的滤过手术更安全，但费用非常高。此外，如果眼压不能立即有效降低，患者可能需要进行后续手术。所有这些因素使得这些手术费用高昂，大多数人无法负担，因此，高昂的手术费用可能会限制市场。

最新动态

  • 2022年1月，Glaukos宣布GLK=301在干眼症II期临床试验中招募了首例患者，在成功获得监管机构批准后，该药物将助力公司业务板块增长。
  • 2022 年 1 月，爱尔康收购了新型 Hydrus Microstent 的开发商 Ivantis，这是一种微创青光眼手术 (MIGS) 设备。该手术设备旨在降低开角型青光眼患者的眼压。此次收购将增强该公司在眼科手术领域的产品组合。

微创青光眼手术 (MIGS) 设备市场范围

微创青光眼手术 (MIGS) 设备市场根据产品、目标、手术、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中的主要增长细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

产品

  • MIGS 支架
  • MIGS 分流器
  • 其他的

根据产品，微创青光眼手术 (MIGS) 设备市场分为 MIGS 分流器、MIGS 支架和其他设备。

目标

  • 小梁网
  • 脉络膜上腔
  • 结膜下滤过
  • 减少水产量

根据目标，微创青光眼手术 (MIGS) 设备市场细分为小梁网、脉络膜上腔、结膜下滤过和减少房水产生。

手术类型

  • 青光眼与白内障
  • 独立性青光眼

根据手术方式，微创青光眼手术 (MIGS) 设备市场分为与白内障相关的青光眼和独立青光眼。

最终用户

  • 医院门诊部（HOPD）
  • 眼科诊所
  • 门诊手术中心（ASCS）
  • 其他的

根据最终用户，微创青光眼手术 (MIGS) 设备市场分为医院门诊部 (HOPD)、眼科诊所、门诊手术中心 (ASCS) 和其他。

分销渠道

  • 直接招标
  • 零售

微创青光眼手术 (MIGS) 设备市场

根据分销渠道，微创青光眼手术（MIGS）设备市场分为直接招标和零售。

微创青光眼手术 (MIGS) 设备市场区域分析/见解

对微创青光眼手术 (MIGS) 设备市场进行了分析，并按国家、产品、目标、手术、最终用户和分销渠道提供了市场规模洞察和趋势，如上所述。

微创青光眼手术（MIGS）设备市场报告涵盖的国家包括北美的美国、加拿大和墨西哥，欧洲的英国、德国、法国、西班牙、意大利、荷兰、瑞士、俄罗斯、比利时、土耳其和欧洲其他地区，亚太地区（APAC）的中国、韩国、日本、印度、澳大利亚、新加坡、马来西亚、印度尼西亚、泰国、菲律宾和亚太其他地区，中东和非洲（MEA）的南非、沙特阿拉伯、阿联酋、以色列、埃及和中东和非洲（MEA）的其他地区，南美洲的巴西、阿根廷和南美洲其他地区。

北美在微创青光眼手术 (MIGS) 设备市场占据主导地位。该地区的增长可归因于该地区青光眼疾病以及其他眼部疾病发病率的上升。美国在北美地区占据主导地位，因为主要市场参与者的合作和收购正在推动市场增长。预计该地区的需求将由市场参与者推动，这些市场参与者专注于扩大其区域产品供应，并通过各种增长战略（如扩张、伙伴关系和协作等）增强其在新兴市场的影响力。

微创青光眼手术 (MIGS) 设备市场

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和微创青光眼手术 (MIGS) 设备市场份额分析

微创青光眼手术 (MIGS) 设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对微创青光眼手术 (MIGS) 设备市场的关注有关。

微创青光眼手术 (MIGS) 设备市场的一些主要参与者包括 AbbVie、BVI、Ellex、Glaukos Corporation、强生、爱尔康、Microsurgical technology、New World Medical、参天制药、Nova Eye Medical Limited、Belkin Vision 和 Sight Scientific 等。

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCTS LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 INTERNATIONAL STANDARDS

4.2 REGIONAL STANDARDS

4.3 MARKET VIEWPOINT OF KEY OPINION LEADERS

4.4 EXPECTATIONS OF FUTURE MARKET SCENARIOS

4.5 FINDINGS AND REGIONAL TRENDS

4.6 COMPETITIVE GROUPING

5 COUNTRY WISE- NO OF PROCEDURES

5.1 NORTH AMERICA

5.2 EUROPE

5.3 ASIA-PACIFIC

5.4 SOUTH AMERICA

5.5 MIDDLE EAST AND AFRICA

6 REGULATION

6.1 UNITED STATES

6.2 EUROPE

6.3 CHINA

6.4 AUSTRALIA

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASE IN THE GERIATRIC POPULATION

7.1.2 RISE IN INCIDENCE OF GLAUCOMA ACROSS THE WORLD

7.1.3 GOVERNMENT INITIATIVES TO INCREASE AWARENESS ABOUT THE PREVENTION OF BLINDNESS

7.1.4 GROWTH IN POPULARITY OF MINIMALLY INVASIVE SURGERY ACROSS THE GLOBE

7.2 RESTRAINTS

7.2.1 INADEQUATE REIMBURSEMENT SCENARIO

7.2.2 STRINGENT REGULATIONS FOR MIGS DEVICES

7.2.3 HIGH COST OF SURGICAL PROCEDURES

7.3 OPPORTUNITIES

7.3.1 RAPID TRANSITION FROM GLAUCOMA MEDICATION TO MINIMALLY INVASIVE GLAUCOMA SURGERIES

7.3.2 INTRODUCTION OF TECHNOLOGICAL ADVANCED PRODUCT

7.4 CHALLENGES

7.4.1 LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE

7.4.2 RISKS ASSOCIATED WITH THE MICRO INVASIVE GLAUCOMA SURGERY

8 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 MIGS STENTS

8.3 MIGS SHUNTS

8.4 OTHERS

9 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET

9.1 OVERVIEW

9.2 TRABECULAR MESHWORK

9.3 SUPRACHOROIDAL SPACE

9.4 SUBCONJUNCTIVAL FILTRATION

9.5 REDUCING AQUEOUS PRODUCTION

10 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE

10.1 OVERVIEW

10.2 GLAUCOMA IN CONJUNCTION WITH CATARACT

10.3 STAND-ALONE GLAUCOMA

11 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER

11.1 OVERVIEW

11.2 HOSPITAL

11.3 OPHTHALMOLOGY CLINICS

11.4 AMBULATORY SURGERY CENTERS (ASCS)

11.5 OTHERS

12 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 DIRECT TENDER

12.3 RETAIL SALES

13 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION

13.1 OVERVIEW

13.2 NORTH AMERICA

13.2.1 U.S.

13.2.2 CANADA

13.2.3 MEXICO

13.3 EUROPE

13.3.1 GERMANY

13.3.2 FRANCE

13.3.3 U.K.

13.3.4 ITALY

13.3.5 SPAIN

13.3.6 SWITZERLAND

13.3.7 NETHERLANDS

13.3.8 BELGIUM

13.3.9 RUSSIA

13.3.10 TURKEY

13.3.11 REST OF EUROPE

13.4 ASIA-PACIFIC

13.4.1 CHINA

13.4.2 JAPAN

13.4.3 INDIA

13.4.4 SOUTH KOREA

13.4.5 AUSTRALIA

13.4.6 SINGAPORE

13.4.7 THAILAND

13.4.8 MALAYSIA

13.4.9 INDONESIA

13.4.10 PHILIPPINES

13.4.11 REST OF ASIA-PACIFIC

13.5 SOUTH AMERICA

13.5.1 BRAZIL

13.5.2 ARGENTINA

13.5.3 REST OF SOUTH AMERICA

13.6 MIDDLE EAST AND AFRICA

13.6.1 SOUTH AFRICA

13.6.2 SAUDI ARABIA

13.6.3 U.A.E.

13.6.4 ISRAEL

13.6.5 EGYPT

13.6.6 REST OF MIDDLE EAST AND AFRICA

14 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: GLOBAL

14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

14.3 COMPANY SHARE ANALYSIS: EUROPE

14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 GLAUKOS CORPORATION

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.4.1 RECENT DEVELOPMENT

 

16.2 ALCON INC.

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.4.1 RECENT DEVELOPMENTS

16.3 ABBVIE INC.

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.4.1 RECENT DEVELOPMENT

16.4 JOHNSON & JOHNSON SURGICAL VISION, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON)

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.4.1 RECENT DEVELOPMENT

16.5 SANTEN PHARMACEUTICAL CO., LTD.

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.4.1 RECENT DEVELOPMENTS

16.6 BELKIN VISION, ISRAEL

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENT

16.7 BVI

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.2.1 RECENT DEVELOPMENTS

16.8 ELLEX INC.

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.2.1 RECENT DEVELOPMENTS

16.9 IOPTIMA

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 MICROSURGICAL TECHNOLOGY. (A SUBSIDIARY OF HALMA PLC)

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.2.1 RECENT DEVELOPMENT

16.11 NEW WORLD MEDICAL, INC.

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.2.1 RECENT DEVELOPMENTS

16.12 NOVA EYE MEDICAL LIMITED

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.3.1 RECENT DEVELOPMENTS

16.13 SIGHT SCIENCES.

16.13.1 COMPANY SNAPSHOT

16.13.2 REVENUE ANALYSIS

16.13.3 PRODUCT PORTFOLIO

16.13.3.1 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

表格列表

TABLE 1 NUMBER OF PEOPLE (AGED 40-80 YEARS, IN MILLIONS) WITH GLAUCOMA IN 2013 AND PROJECTION OF THE NUMBER OF PEOPLE HAVING GLAUCOMA IN 2020 AND 2040

TABLE 2 NEW OPTIONS FOR GLAUCOMA TREATMENT

TABLE 3 NUMBER OF PHYSICIANS/ THOUSAND POPULATIONS

TABLE 4 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 5 GLOBAL MIGS STENTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 GLOBAL MIGS SHUNTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 GLOBAL OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 9 GLOBAL TRABECULAR MESHWORK IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 GLOBAL SUPRACHOROIDAL SPACE IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 GLOBAL SUBCONJUNCTIVAL FILTRATION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 GLOBAL REDUCING AQUEOUS PRODUCTION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 14 GLOBAL GLAUCOMA IN CONJUNCTION WITH CATARACT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 GLOBAL STAND-ALONE GLAUCOMA IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 17 GLOBAL HOSPITAL IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 GLOBAL OPHTHALMOLOGY CLINICS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 GLOBAL AMBULATORY SURGERY CENTERS (ASCS) IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 GLOBAL OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 22 GLOBAL DIRECT TENDER IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 GLOBAL RETAIL SALES IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 26 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 27 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 28 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 29 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 30 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 31 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 32 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 33 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 34 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 35 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 36 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 37 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 38 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 39 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 40 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 41 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 42 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 43 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 44 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 45 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 46 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 47 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 48 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 49 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 50 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 51 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 52 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 53 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 54 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 55 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 56 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 57 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 58 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 59 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 60 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 61 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 62 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 63 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 64 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 65 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 66 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 67 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 68 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 69 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 70 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 71 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 72 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 73 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 74 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 75 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 76 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 77 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 78 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 79 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 80 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 81 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 82 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 83 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 84 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 85 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 86 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 87 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 88 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 89 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 90 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 91 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 92 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 93 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 94 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 95 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 96 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 97 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 98 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 99 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 100 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 101 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 102 REST OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 103 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 104 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 105 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 106 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 107 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 108 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 109 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 110 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 111 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 112 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 113 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 114 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 115 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 116 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 117 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 118 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 119 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 120 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 121 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 122 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 123 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 124 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 125 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 126 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 127 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 128 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 129 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 130 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 131 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 132 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 133 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 134 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 135 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 136 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 137 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 138 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 139 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 140 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 141 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 142 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 143 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 144 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 145 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 146 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 147 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 148 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 149 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 150 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 151 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 152 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 153 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 154 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 155 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 156 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 157 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 158 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 159 REST OF ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 160 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 161 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 162 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 163 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 164 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 165 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 166 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 167 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 168 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 169 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 170 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 171 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 172 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 173 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 174 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 175 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 176 REST OF SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 177 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 178 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 179 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 180 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 181 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 182 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 183 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 184 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 185 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 186 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 187 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 188 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 189 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 190 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 191 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 192 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 193 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 194 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 195 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 196 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 197 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 198 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 199 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 200 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 201 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 202 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 203 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 204 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)

TABLE 205 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)

TABLE 206 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 207 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 208 REST OF MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION

FIGURE 2 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: MARKET END USER GRID

FIGURE 9 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION

FIGURE 11 INCREASING GERIATRIC POPULATIONAND RISING PREVALENCE OF GLAUCOMA IS EXPECTED TO DRIVE THE GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 PRODUCT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLAUCOMA SURGERY (MIGS) DEVICES MARKET

FIGURE 14 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, 2021

FIGURE 15 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, 2022-2029 (USD MILLION)

FIGURE 16 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, CAGR (2022-2029)

FIGURE 17 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2021

FIGURE 19 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2022-2029 (USD MILLION)

FIGURE 20 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, CAGR (2022-2029)

FIGURE 21 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, LIFELINE CURVE

FIGURE 22 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2021

FIGURE 23 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2022-2029 (USD MILLION)

FIGURE 24 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, CAGR (2022-2029)

FIGURE 25 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE

FIGURE 26 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2021

FIGURE 27 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 28 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, CAGR (2022-2029)

FIGURE 29 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 31 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 32 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 33 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 34 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)

FIGURE 35 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY REGION (2021)

FIGURE 36 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY REGION (2022 & 2029)

FIGURE 37 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY REGION (2021 & 2029)

FIGURE 38 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)

FIGURE 39 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)

FIGURE 40 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)

FIGURE 41 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 42 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 43 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)

FIGURE 44 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)

FIGURE 45 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)

FIGURE 46 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 47 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 48 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)

FIGURE 49 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)

FIGURE 50 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)

FIGURE 51 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 52 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 53 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)

FIGURE 54 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)

FIGURE 55 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)

FIGURE 56 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 57 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 58 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)

FIGURE 59 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)

FIGURE 60 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)

FIGURE 61 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 62 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 63 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)

FIGURE 64 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2021 (%)

FIGURE 65 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2021 (%)

FIGURE 66 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2021 (%)

FIGURE 67 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2021 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Micro Invasive Glaucoma Surgery (MIGS) Devices Market value is expected USD 5,995.46 million by 2029.
The Micro Invasive Glaucoma Surgery (MIGS) Devices Market is to grow at a CAGR of 33.3% during the forecast by 2029.
The major players operating in the Micro Invasive Glaucoma Surgery (MIGS) Devices Market are AbbVie, BVI, Ellex, Glaukos Corporation, Johnson and Johnson, Alcon, Microsurgical technology, New World Medical, Santen Pharmaceutical, Nova Eye Medical Limited, etc.
The major countries covered in the Micro Invasive Glaucoma Surgery (MIGS) Devices Market are U.S., Canada, Mexico in North America. U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe in Europe. China, South Korea, Japan, India, etc.

浏览相关页面

Banner